XML 17 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Financial Condition - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Cash and cash equivalents:    
Cash and due from banks $ 2,014,523 $ 2,142,294
Money market investments 8,952 11,908
Total cash and cash equivalents 2,023,475 2,154,202
Restricted cash 175 1,375
Investments:    
Trading securities, at fair value, with amortized cost of $162 (December 31, 2020 - $432) 20 22
Investment securities available-for-sale, at fair value, with amortized cost of $503,421 (December 31, 2020, amortized cost $432,176); no allowance for credit losses 510,713 446,438
Investment securities held-to-maturity, at amortized cost, with fair value of $363,653; no allowance for credit losses 367,507 0
Equity securities 17,578 12,240
Total investments 895,818 458,700
Loans:    
Loans held-for-sale, at lower of cost or fair value 82,662 43,935
Loans held for investment, net of allowance for credit losses of $155,937 (December 31, 2020 - $204,809) 6,246,649 6,457,324
Total loans 6,329,311 6,501,259
Other assets:    
Foreclosed real estate 15,039 11,596
Accrued interest receivable 56,560 65,547
Deferred tax asset, net 99,063 162,478
Premises and equipment, net 92,124 83,786
Customers' liability on acceptances 35,329 33,349
Servicing assets 48,973 47,295
Goodwill 86,069 86,069
Other intangible assets 36,093 45,896
Operating lease right-of-use assets 28,846 31,383
Other assets 152,845 143,076
Total assets 9,899,720 9,826,011
Deposits:    
Demand deposits 5,204,340 4,613,309
Savings accounts 2,177,780 1,944,415
Time deposits 1,220,998 1,857,916
Total deposits 8,603,118 8,415,640
Borrowings:    
Advances from FHLB 28,488 65,561
Subordinated capital notes 36,083 36,083
Other borrowings 0 707
Total borrowings 64,571 102,351
Other liabilities:    
Derivative liabilities 804 1,712
Acceptances executed and outstanding 35,329 33,349
Operating lease liabilities 30,498 32,566
Accrued expenses and other liabilities 96,240 154,418
Total liabilities 8,830,560 8,740,036
Commitments and contingencies (See Note 26)
Stockholders’ equity:    
Preferred stock; 10,000,000 shares authorized; (December 31, 2020 - 1,340,000 shares of Series A; 1,380,000 shares of Series B; and 960,000 shares of Series D issued and outstanding) $25 liquidation value 0 92,000
Common stock, $1 par value; 100,000,000 shares authorized; 59,885,234 shares issued: 49,636,352 shares outstanding (December 31, 2020 - 59,885,234 shares issued; 51,387,071 shares outstanding) 59,885 59,885
Additional paid-in capital 637,061 622,652
Legal surplus 117,677 103,269
Retained earnings 399,949 300,096
Treasury stock, at cost, 10,248,882 shares (December 31, 2020 - 8,498,163 shares) (150,572) (102,949)
Accumulated other comprehensive income, net of tax of $1,328 (December 31, 2020 - $1,529) 5,160 11,022
Total stockholders’ equity 1,069,160 1,085,975
Total liabilities and stockholders’ equity $ 9,899,720 $ 9,826,011